Liraglutide hit the headlines in January because it had just been approved by the European Medicines Agency (EMA) for the treatment of obesity, to be marketed as “Saxenda”. The EMA had previously approved it for type 2 diabetes in July 2009. In America the approval for obesity had come a month earlier in December 2014.
Current Posts – 16 March 2015
Dietitians are the people we trust to give us the best and latest information about how to lose weight or what is a healthy balanced diet. But should we? Food companies are now involved in setting national guidelines on food. Can we really rely on dietitians to challenge the financial muscle of Big Food? A recent investigation suggests not.